# CJC-1295 (No DAC) & Ipamorelin - CJC-1295 (No DAC) and Ipamorelin supplied as one vial containing a 10 mg research blend, tied to the batch record. CJC-1295 No DAC & Ipamorelin research-use-only blend - one freeze-dried 10 mg vial, current certification unverified, dispatched from Perth. ## At a glance | | | | --- | --- | | Compound | CJC-1295 (No DAC) & Ipamorelin | | Descriptor | No-DAC and GHS-R1a research blend | | Current certificate | Not verified for listed lot | | Storage | 2-8 C | | Format | Freeze-dried powder | | Availability | In stock | | Lot | CJCI-2506 | ## Sizes and pricing (AUD) | | | | --- | --- | | 10 mg | $80 AUD | ## Certificate status Matching current certificate unavailable. No verified report matches the listed compound, lot and amount. No matching current certificate is displayed for this product. ## What is in the CJC-1295 (No DAC) and Ipamorelin set? CJC-1295 (No DAC) is the short-acting Modified GRF(1-29) form. The with DAC form carries an albumin-binding Drug Affinity Complex, so papers on that longer-acting form are treated as background rather than direct No-DAC evidence. Ipamorelin is a separate five-amino-acid peptide, also known as NNC 26-0161. It is described in the literature as a selective growth-hormone secretagogue acting at the ghrelin receptor, GHS-R1a, and its clinical development was later discontinued. The set is described as a research comparison of two pathway classes: a GHRH analog and a ghrelin-receptor agonist. Neither compound supplies GH or IGF-1, and the page does not describe human or veterinary use. ## Specifications One unit is one vial containing a 10 mg blend; pack options count vials. CJC-1295 (No DAC) is listed as Modified GRF(1-29), while Ipamorelin is listed as NNC 26-0161 with its own CAS, formula, and molecular weight. | | | | --- | --- | | Compound A | CJC-1295 No DAC / Modified GRF (1-29) | | CJC-1295 No DAC formula | C152H252N44O42 | | CJC-1295 No DAC MW | 3367.9 g/mol | | Compound B | Ipamorelin / NNC 26-0161 | | Ipamorelin CAS | 170851-70-4 | | Ipamorelin formula | C38H49N9O5 | | Ipamorelin MW | 711.9 g/mol | | Lot | CJCI-2506 | ## What the research looks at CJC-1295 (No DAC) sits in GHRH analog research as Modified GRF(1-29). Ipamorelin sits in growth-hormone secretagogue research as a ghrelin-receptor agonist at GHS-R1a. Teichman and colleagues reported limited human pharmacokinetic data for the with DAC albumin-binding form, not for the No-DAC material listed here. That distinction keeps DAC-form evidence in the right context. Neither CJC-1295 (No DAC) nor Ipamorelin is listed on the ARTG, and the TGA has not evaluated either as a medicine. WADA lists GHRH analogs and growth-hormone secretagogues, including CJC-1295 and Ipamorelin, as prohibited substances in sport. ## Frequently asked questions ### What is CJC-1295 (No DAC) & Ipamorelin supplied for? CJC-1295 (No DAC) & Ipamorelin is supplied as laboratory research material only. It is 21+ only, not for human consumption, and not for veterinary use. ### Does this page include matching COA information? The product page lists catalog lot, appearance and storage notes for CJC-1295 (No DAC) & Ipamorelin. Available original reports are labelled by sample; matching current certification is unavailable where the compound, lot or amount differs. A heavy-metals screen does not measure purity or confirm identity. ### How should the vial be handled after delivery? Follow the label and your laboratory's written procedures. Do not treat a historical sample report as current lot documentation. This page repeats 2-8 C storage guidance and light-protection notes before checkout. ### What is CJC-1295 (No DAC)? CJC-1295 (No DAC) is a synthetic analog of growth-hormone-releasing hormone (GHRH), also called Modified GRF(1-29). It is the short-acting No DAC form, not the with DAC albumin-binding form. It is supplied as a research-use-only reference material, not an approved medicine. ### What is Ipamorelin? Ipamorelin is NNC 26-0161, a selective growth-hormone secretagogue and five-amino-acid agonist at the ghrelin receptor, GHS-R1a. It was first described in 1998 and studied for the ghrelin-receptor pathway. Its clinical development was discontinued, and it is not an approved medicine. ### Why are CJC-1295 and Ipamorelin studied together? CJC-1295 (No DAC) and Ipamorelin are studied together because they sit on two different GH-axis research pathways: GHRH analog research and ghrelin-receptor agonist research. Published context discusses the body's own GH release and related IGF-1 signalling. Neither peptide supplies GH or IGF-1 directly. ### Are CJC-1295 or Ipamorelin approved medicines? Neither CJC-1295 (No DAC) nor Ipamorelin is an approved medicine in Australia. Neither is listed on the ARTG, and the TGA has not evaluated either for safety, quality, or effectiveness. Form Labs supplies both strictly as laboratory research materials. ### Are CJC-1295 and Ipamorelin on the WADA list? CJC-1295 and Ipamorelin are on the World Anti-Doping Agency (WADA) Prohibited List. Growth-hormone-releasing hormone analogs and growth-hormone secretagogues are banned in and out of competition. Current status should be confirmed directly with WADA. ### How do I order? A Form Labs order is placed through checkout, then paid by bank transfer using the invoice reference emailed for the order. Once the transfer clears, Form Labs packs the order and emails tracking. PayID or Osko transfers can clear faster. ### What does research use only mean here? Research use only means CJC-1295 (No DAC) and Ipamorelin are supplied as laboratory reference materials for in-vitro research. They are not medicines, supplements, foods, or materials for human or animal use. The page describes compound identity and published research context, not instructions for use. ## References - CJC DAC caveat: Jette L et al. Endocrinology. 2005;146(7):3052-3058. DOI: 10.1210/en.2004-1286 - GHS receptor context: Howard AD et al. Science. 1996;273(5277):974-977. DOI: 10.1126/science.273.5277.974 - Ipamorelin identity: Raun K et al. European Journal of Endocrinology. 1998;139(5):552-561. DOI: 10.1530/eje.0.1390552 This summary is for scientific and educational context only. It is not preparation guidance, administration guidance, or a statement about use in people or animals. --- Canonical page: https://www.formlaboratories.com/shop/cjc-1295-ipamorelin Form Laboratories - Perth-based research-use-only peptide supplier, shipping Australia-wide. - Site guide for agents: https://www.formlaboratories.com/llms.txt - Sitemap: https://www.formlaboratories.com/sitemap.xml - Full catalogue: https://www.formlaboratories.com/shop - Contact: hello@formlaboratories.com All materials are supplied for laboratory research use only - not for human or veterinary use, and nothing on this site is medical advice.